Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients

Filiz Oezkan (Bochum, Germany), Filiz Oezkan, Amir Khan, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kazuhiro Yasufuku, Takahiro Nakajima, Ruediger Karpf-Wissel, Diana Hartmann, Dirk Theegarten, Lutz Freitag, Kaid Darwiche

Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Session: Endoscopic ultrasound: an essential tool for interventional pulmonology
Session type: Thematic Poster Session
Number: 771
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Filiz Oezkan (Bochum, Germany), Filiz Oezkan, Amir Khan, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kazuhiro Yasufuku, Takahiro Nakajima, Ruediger Karpf-Wissel, Diana Hartmann, Dirk Theegarten, Lutz Freitag, Kaid Darwiche. Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients. Eur Respir J 2015; 46: Suppl. 59, 771

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013


Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016

Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Genetic mutations in transbronchial lung biopsy of peripheral lesions
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016


Cytology sample from EBUS-TBNA for multi-gene analysis in non-small-cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Prevalence of preinvasive bronchial lesions in patients with lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Prevalence of molecular changes in resected pulmonary adenocarcinomas
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013


Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


EBUS-TBNA in the diagnosis of haematological malignancies; overcoming the challenge
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015

Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013

Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Feasibility of OSNA in EBUS-TBNA of lung cancer patients
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014

Serum and bronchial aspiration fluid HE-4 levels in lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015